Evidence map›Paper›PMID 39388677›Full record

ArticleCancer communications (London, England)2024

Genomic imprinting biomarkers for cervical cancer risk stratification.

Xue Xiao, Wei Wang, Peng Bai, Ying Chen, Zhengwen Qin, Tong Cheng, Xing Li, John P Pineda, Panying Shi, Xiaonan Wang and 15 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer communications (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Xue XiaoDepartment of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.
Wei WangKey Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.
Peng BaiDepartment of Forensic Genetics, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, Sichuan, P. R. China.
Ying ChenDepartment of Obstetrics and Gynecology, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, P. R. China.
Zhengwen QinDepartment of Gynecology, Zigong Maternity and Child Health Care Hospital, Zigong, Sichuan, P. R. China.
Tong ChengLisen Imprinting Diagnostics Wuxi, Ltd., Wuxi, Jiangsu, P. R. China.
Xing LiLisen Imprinting Diagnostics Wuxi, Ltd., Wuxi, Jiangsu, P. R. China.
John P PinedaLisen Imprinting Diagnostics Wuxi, Ltd., Wuxi, Jiangsu, P. R. China.
Panying ShiLisen Imprinting Diagnostics Wuxi, Ltd., Wuxi, Jiangsu, P. R. China.
Xiaonan WangLisen Imprinting Diagnostics Wuxi, Ltd., Wuxi, Jiangsu, P. R. China.
Jianhong WangDepartment of Gynecology, Chengdu Chenghua District Maternal and Child Health Center, Chengdu, Sichuan, P. R. China.
Lian XuKey Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.
Xuemei GaoDepartment of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.
Huixian ZhengDepartment of Gynecology, Zigong Maternity and Child Health Care Hospital, Zigong, Sichuan, P. R. China.
Lulu YangDepartment of Pathology, Nanjing First Hospital, Nanjing, Jiangsu, P. R. China.
Wenyi LinDepartment of Pathology, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, P. R. China.
Wenbin HuangDepartment of Pathology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, P. R. China.
Rulong ShenDepartment of Pathology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Changjun YueDepartment of Pathology, Harbor-UCLA Medical Center, Torrance, California, USA.
Huixiong XuDepartment of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Felipe BataliniDivision of Medical Oncology, Mayo Clinic Arizona, Phoenix, Arizona, USA.
Yang LiuDepartment of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, Sichuan, P. R. China.
Ning ZhouLisen Imprinting Diagnostics Wuxi, Ltd., Wuxi, Jiangsu, P. R. China.
Yaoyao ZhangDepartment of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.
Hanmin LiuKey Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.ORCID https://orcid.org/0000-0002-4633-911X

Funding

Chengdu Science and Technology Bureau 2017-GH02-00030-HZChengdu Technological Innovation R&D Project 2021-YF05-00595-SNLisen Imprinting Diagnostics, Inc.National Key Research and Development Program of China 2022YFC2704700National Key Research and Development Program of China 2022YFC3600304National Natural Science Foundation of China 82071651Science and Technology Department of Sichuan Province 23ZDYF2489Sichuan Province Cadre Health Care Scientific Research Project CGY2023-1701
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39388677
PMCPMC11666962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.